Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2009
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
10/2009
10/29/2009WO2009131246A1 Sordarin derivatives for preventing or treating infectious diseases caused by pathogenic microorganisms
10/29/2009WO2009130422A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009WO2009130386A1 A process for recovery of formic acid
10/29/2009WO2009103534A3 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270639 Process for production of (±)-3a,6,6,9a- tetramethyldecahydronaphtho[2,1-b]furan-2(1h)-one
10/29/2009US20090270608 Method for conversion of carbohydrate polymers to value-added chemical products
10/29/2009US20090270496 Antifungal compounds
10/29/2009US20090270493 prodrugs of gabapentin and pregabalin, such as 2-[1-[[[(2R)-6-oxooxan-2-yl]oxycarbonylamino]methyl]cyclohexyl]aceticacid, used for for treating epilepsy, depression, anxiety, psychosis, brain disorders, neurodegenerative diseases, pain, inflammatory disease, gastrointestinal disorders or drug abuse
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090269323 Non-amphiphile-based water-in-water emulsion and uses thereof
10/29/2009DE102007049630A1 New amide compounds used for therapy and/or prophylaxis of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy
10/29/2009CA2722258A1 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009CA2721168A1 A process for preparation of formate salt
10/29/2009CA2721165A1 A process for recovery of formic acid
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/28/2009EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009EP2111398A2 Spirocyclic tetronic acid derivatives
10/28/2009EP1692098B1 Alpha-ketoamide derivative, and production method and use thereof
10/28/2009CN101565435A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
10/28/2009CN101565418A Amide derivative and purpose thereof
10/28/2009CN101565412A Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
10/28/2009CN101564632A Process for recovering benzene-containing tail gas from preparation of cis-butenedioic anhydride by benzene oxidation
10/28/2009CN100554260C Fukinanolide compounds and pharmaceutical application thereof
10/28/2009CN100554259C 2-benzo(C) foroxone compound, its production and use
10/27/2009US7608727 reacting methyl acrylate, propionaldehyde in presence of phosphovanadomolybdic acids or phosphomolybdic acids, and palladium acetate catalyst and a Lewis acid ( CeCL3.7H2O)in methanol and acetic acid as solvent in oxygen atmosphere to form methyl 5-methylfuran-3-carboxylate
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/22/2009WO2009129350A2 A novel process for the preparation of sodium gamma-hydroxybutyrate
10/22/2009WO2009127723A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009WO2009127321A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
10/22/2009WO2009127116A1 13-halo-3,15-dioxy gibberellic acid esters and the preparation methods thereof
10/22/2009US20090264620 N-Methylation of amino acids
10/22/2009US20090264521 Percutaneous absorption preparation
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009CA2721785A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009CA2721591A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
10/21/2009EP2110380A1 Alpha-N-methylation of amino acids
10/21/2009EP2110374A1 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
10/21/2009EP2109601A2 Preparation of darifenacin and its salts
10/21/2009EP2044046B1 Substituted n-acyl homoserine lactones
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009CN101560200A Extracting method of angelica ligustilide
10/21/2009CN101560199A Preparation method of Escitalopram
10/21/2009CN101560198A New isoandrographolidume sulfonate, pharmaceutical composition containing sulfonate, preparation method and applications thereof
10/21/2009CN101560167A Alpha-n-methylation of amino acids
10/21/2009CN101560136A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101559088A Production technique of andrographolide and neoandrographolide, dehydroanddrographolide, oxyandrographolide
10/21/2009CN100552044C Process for producing leather and compounds suitable therefor
10/21/2009CN100551920C Method and apparatus for purification of furfuryl alcohol
10/20/2009US7605286 Reacting with an acetal type protecting group such as methoxymethyl group, 2-(R-oxymethoxy-),3-haloprop-1-ene (R is phenyl or acyclic); stability; deprotecting under mild acidic conditions;industrial application; fungicides, viricides, HIV; antilipemic agents; obesity
10/20/2009US7605275 Exo- and diastereo- selective syntheses of himbacine analogs
10/20/2009US7605262 Podophyllotoxin derivatives
10/20/2009US7605259 Structurally rigid dopamine d3 receptor selective ligands and process for making them
10/20/2009US7605158 Carbamoyl-type benzofuran derivatives
10/20/2009US7605111 Herbicides
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/15/2009WO2009125938A2 Novel platensimycin derivatives, their intermediates, and process for prepararing the same, and new process for preparing platensimycin
10/15/2009WO2009124968A1 Novel estrogen receptor ligands
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009WO2009124946A1 Method for starting a gas-phase oxidation reactor
10/15/2009WO2009085344A3 Dibenzothiophene, dibenzofuran and/or carbazole-containing materials in phosphorescent light emitting diodes
10/15/2009WO2009076627A3 Conversion of carbohydrates to hydroxy-methylfurfural (hmf) and derivatives
10/15/2009US20090259058 Process for the Preparation of Prostaglandin Analogues and Intermediates Thereof
10/15/2009US20090258912 N-(1-Alkyl-2-Phenylethyl)-Carboxamide Derivatives and Use Thereof as Fungicides
10/15/2009US20090258321 Light absorbent and organic antireflection coating composition containing the same
10/15/2009CA2720530A1 Sulfonamides
10/14/2009EP1877367B1 Acetylene derivatives
10/14/2009CN101558053A Novel inhibitors of chymase
10/14/2009CN101558052A Process for one-stage preparation of 2-methyltetrahydrofuran from furfural over two catalysts in a structured bed
10/14/2009CN101555239A Method for extracting vitamin C and 2-keto-L-gulonic acid from vitamin C mother liquor
10/14/2009CN101555238A Method for tetrahydrofuran recycling
10/14/2009CN101555237A New monoterpene compounds and preparation method thereof
10/14/2009CN100549061C Method for producing elastomeric copolyesters
10/14/2009CN100549003C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548982C Heteropolycyclic compound and dye
10/14/2009CN100548939C Method for the separation of intermediates which may be used for the preparation of escitalopram
10/13/2009US7601874 Antiinflammatory agents; antiarthritic agents; brain disorders; multiple sclerosis; gout; inflammatory bowel disorders; gastrointestinal disorders; psoriasis; antiallergens; autoimmune disease
10/13/2009US7601856 Such as 2,2-Dimethyl-N-(6,7,8,9-tetrahydro-dibenzofuran-2-yl)-propionamide
10/13/2009US7601854 Diterpenes from the fruiting body of Antrodia camphorata and pharmaceutical compositions thereof
10/13/2009US7601820 Anti-Hepatitis c nucleosides containing 2-deoxy-2-fluoro-2-C-methyl- beta -D-ribofuranosyl nucleosides from a naturally-occurring nucleoside; Ethyl trans-2,3-dideoxy-4,5-O-isopropylidene-2-C-methyl-D-glycero-pent-2-enonate
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/08/2009WO2009124022A1 2 -aminotetralin derivatives as mu opioid receptor antagonists
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009122447A1 Semi-synthetic sesquiterpene lactone parthenin compound useful for cytotoxicity against cancer cell lines and anticander agent
10/08/2009WO2009121869A1 Diamine salts of carboxylic acids
10/08/2009WO2009121735A1 Process for separating off fumaric acid and other minor components during the production of maleic anhydride
10/08/2009WO2009121535A2 Antiproliferative compounds and therapeutic uses thereof
10/08/2009WO2009077606A3 Gasoline composition and process for the preparation of alkylfurfuryl ether
10/08/2009US20090253921 Aerobic oxidative coupling for the formation of biaryls
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253703 Organic compounds
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/08/2009US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 472